Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Outbreak of OXY-2-Producing Klebsiella oxytoca in a renal transplant unit.

Zárate MS, Gales AC, Picão RC, Pujol GS, Lanza A, Smayevsky J.

J Clin Microbiol. 2008 Jun;46(6):2099-101. doi: 10.1128/JCM.00194-08. Epub 2008 Apr 16.

2.

Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase.

Jeong SH, Kim WM, Chang CL, Kim JM, Lee K, Chong Y, Hwang HY, Baek YW, Chung HK, Woo IG, Ku JY.

J Hosp Infect. 2001 Aug;48(4):281-8.

PMID:
11461129
3.

Nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Klebsiella oxytoca in Austria.

Hoenigl M, Valentin T, Zarfel G, Wuerstl B, Leitner E, Salzer HJ, Posch J, Krause R, Grisold AJ.

Antimicrob Agents Chemother. 2012 Apr;56(4):2158-61. doi: 10.1128/AAC.05440-11. Epub 2012 Jan 30.

4.
5.

Outbreak of extended-spectrum β-lactamase-producing Klebsiella oxytoca infections associated with contaminated handwashing sinks(1).

Lowe C, Willey B, O'Shaughnessy A, Lee W, Lum M, Pike K, Larocque C, Dedier H, Dales L, Moore C, McGeer A; Mount Sinai Hospital Infection Control Team.

Emerg Infect Dis. 2012 Aug;18(8):1242-7. doi: 10.3201/eid1808.111268.

6.

Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit.

Arena F, Giani T, Becucci E, Conte V, Zanelli G, D'Andrea MM, Buonocore G, Bagnoli F, Zanchi A, Montagnani F, Rossolini GM.

J Clin Microbiol. 2013 Dec;51(12):4067-72. doi: 10.1128/JCM.01982-13. Epub 2013 Oct 2.

7.

Ceftazidime-resistant Klebsiella oxytoca producing an OXY-2-type variant from Switzerland.

Rodríguez-Martínez JM, Poirel L, Nordmann P, Fankhauser C, Francois P, Schrenzel J.

Int J Antimicrob Agents. 2008 Sep;32(3):278-9. doi: 10.1016/j.ijantimicag.2008.04.002. Epub 2008 Jul 3. No abstract available.

PMID:
18602252
8.

Mechanism of resistance and antibacterial susceptibility in extended-spectrum β-lactamase phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan.

Sato T, Hara T, Horiyama T, Kanazawa S, Yamaguchi T, Maki H.

J Med Microbiol. 2015 May;64(Pt 5):538-43. doi: 10.1099/jmm.0.000057. Epub 2015 Mar 26.

PMID:
25813819
9.

First isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal.

Conceição T, Brízio A, Duarte A, Barros R.

Antimicrob Agents Chemother. 2005 Jan;49(1):476. No abstract available.

10.

Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.

Li Y, Li Q, Du Y, Jiang X, Tang J, Wang J, Li G, Jiang Y.

J Clin Microbiol. 2008 Apr;46(4):1317-21. doi: 10.1128/JCM.00073-07. Epub 2008 Feb 27.

11.

Isolation of multidrug-resistant Klebsiella oxytoca carrying blaIMP-8, associated with OXY hyperproduction, in the intensive care unit of a community hospital in Spain.

Conejo MC, Domínguez MC, López-Cerero L, Serrano L, Rodríguez-Baño J, Pascual A.

J Antimicrob Chemother. 2010 May;65(5):1071-3. doi: 10.1093/jac/dkq063. Epub 2010 Mar 9. No abstract available.

12.

Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.

Gootz TD, Lescoe MK, Dib-Hajj F, Dougherty BA, He W, Della-Latta P, Huard RC.

Antimicrob Agents Chemother. 2009 May;53(5):1998-2004. doi: 10.1128/AAC.01355-08. Epub 2009 Mar 2.

13.

Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.

Chen LR, Zhou HW, Cai JC, Zhang R, Chen GX.

Diagn Microbiol Infect Dis. 2009 Oct;65(2):163-7. doi: 10.1016/j.diagmicrobio.2009.07.002.

PMID:
19748427
14.

Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.

Rasheed JK, Biddle JW, Anderson KF, Washer L, Chenoweth C, Perrin J, Newton DW, Patel JB.

J Clin Microbiol. 2008 Jun;46(6):2066-9. doi: 10.1128/JCM.02038-07. Epub 2008 Apr 2.

15.

Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.

Kim JY, Park YJ, Kim SI, Kang MW, Lee SO, Lee KY.

J Antimicrob Chemother. 2004 Dec;54(6):1144-7. Epub 2004 Nov 16.

16.

Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital.

Tokatlidou D, Tsivitanidou M, Pournaras S, Ikonomidis A, Tsakris A, Sofianou D.

J Clin Microbiol. 2008 Mar;46(3):1005-8. doi: 10.1128/JCM.01573-07. Epub 2008 Jan 16.

17.

Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei.

Nadjar D, Rouveau M, Verdet C, Donay L, Herrmann J, Lagrange PH, Philippon A, Arlet G.

FEMS Microbiol Lett. 2000 Jun 1;187(1):35-40.

18.

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Woodford N, Tierno PM Jr, Young K, Tysall L, Palepou MF, Ward E, Painter RE, Suber DF, Shungu D, Silver LL, Inglima K, Kornblum J, Livermore DM.

Antimicrob Agents Chemother. 2004 Dec;48(12):4793-9.

19.

Detection and spread of oxa-48-producing Klebsiella oxytoca isolates in Istanbul, Turkey.

Nazik H, Aydin S, Albayrak R, Bilgi EA, Yildiz I, Kuvat N, Kelesoglu FM, Kelesoglu FM, Pakaştiçali N, Yilmaz F, Ongen B.

Southeast Asian J Trop Med Public Health. 2014 Jan;45(1):123-9.

PMID:
24964661
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk